- Release Date: 23/11/22 08:54
- Summary: Long-Term Survival for Acute GvHD Treatment with Remestemcel
- Price Sensitive: No
- Download Document 189.85KB
- Forums
- ASX - By Stock
- MSB
- Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
MSB
mesoblast limited
Add to My Watchlist
0.00%
!
$2.29

Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
-
- There are more pages in this discussion • 296 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$2.29 |
Change
0.000(0.00%) |
Mkt cap ! $2.931B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 10601 | $2.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.15 | 529 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 2.400 |
1 | 4447 | 2.370 |
2 | 7597 | 2.360 |
1 | 161 | 2.320 |
2 | 2274 | 2.300 |
Price($) | Vol. | No. |
---|---|---|
2.150 | 529 | 2 |
2.180 | 153 | 1 |
2.190 | 4692 | 5 |
2.200 | 231 | 1 |
2.210 | 243 | 1 |
Last trade - 09.55am 12/08/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |